Recent Updates
Recently added Catalysts
AMN Positive Sentiment Score: 70/100

AMN Healthcare Launches $400.0 Million Offering of Senior Notes DALLAS

Key Takeaway: AMN Healthcare Services has announced a private offering of $400 million in senior unsecured notes due 2031. Proceeds from this offering will primarily be used to redeem outstanding $500 million senior notes due 2027. The successful completion of this offering is crucial for the planned redemption, and it comes with certain market conditions. This move aims to enhance the company's capital structure and financial flexibility.

Market Sentiment Analysis

POSITIVE FACTORS

  • AMN Healthcare is securing $400 million in funding through a private offering.
  • The new senior notes will enable AMN to redeem older debt, potentially improving financial stability.
  • This offering reflects AMN's ongoing commitment to optimize their capital structure.

CONCERNS & RISKS

  • The offering is subject to market and other conditions, introducing uncertainty.
  • There is no guarantee of successful completion of the 2031 Notes offering, which affects the redemption of the 2027 Notes.

Full Press Release Details

AMN Healthcare Launches $400.0 Million Offering
DALLAS, Sept. 22, 2025 -- AMN Healthcare Services,
Inc. (NYSE: AMN), announced today that its wholly owned subsidiary, AMN Healthcare, Inc., intends to make a private offering of $400.0
million aggregate principal amount of senior unsecured notes due 2031, subject to market and other conditions. The 2031 Notes will be
guaranteed by the Company's affiliates that guarantee the Company's credit facilities.
The Company intends to use the proceeds from the
private offering, together with cash on hand and borrowings under the Company's secured revolving credit facility, (i) to redeem
all of the $500.0 million aggregate principal amount of its 4.625% senior unsecured notes due 2027 outstanding and (ii) to pay fees and
expenses related to the offering.
The Company expects to deliver a Conditional Notice
of Redemption to holders of its outstanding 2027 Notes, which will provide for the redemption by the Company of all of the $500.0 million
aggregate principal amount of 2027 Notes outstanding, subject to the successful completion of offering of the 2031 Notes.
The 2031 Notes will be offered only to persons
reasonably believed to be qualified institutional buyers in reliance on Rule 144A under the Securities Act of 1933, as amended, and to
non-U.S. persons outside of the United States in compliance with Regulation S under the Securities Act. The 2031 Notes will not be registered
under the Securities Act and may not be offered or sold in the United States absent registration or an applicable exemption from registration
This press release does not constitute an offer
to sell or the solicitation of an offer to buy the 2031 Notes, nor shall it constitute an offer, solicitation or sale in any jurisdiction
in which such offer, solicitation or sale is unlawful.
About AMN Healthcare
AMN Healthcare is the leader and
innovator in total talent solutions for healthcare, bringing together the people, processes and technology to deliver better care. Through
a steadfast partnership approach, we solve the most pressing workforce challenges to enable better clinical outcomes and access to care.
In 2024, our healthcare professionals reached nearly 15 million patients at more than 2,100 healthcare systems, including 87 percent of
the top healthcare systems nationwide. We provide a comprehensive network of quality healthcare professionals and deliver a fully integrated
and customizable suite of workforce technologies.
Forward-Looking Statements
This press release contains "forward-looking
statements" within the meaning of Section 27A of the Securities Act and Section 21E of the Securities Exchange Act of 1934, as amended.
Actual results could differ materially from those discussed in, or implied by, these forward-looking statements. Forward-looking statements
are identified by words such as "believe," "anticipate," "expect," "intend," "plan,"
"will," "should," "would," "project," "may," "estimates," variations
of such words and other similar expressions. In addition, any statements that refer to expectations, projections or other characterizations
of future events or circumstances are forward-looking statements. Factors that could cause actual results to differ from those implied
by the forward-looking statements contained in this press release are set forth in the Company's Annual Report on Form 10-K for
the year ended December 31, 2024 and its other periodic reports as well as the Company's current and other reports filed from time
to time with the Securities and Exchange Commission. Be advised that developments subsequent to this press release are likely to cause
these statements to become outdated.
Vice President, Investor Relations & Strategy

Frequently Asked Questions

What is the amount of AMN Healthcare's private offering?

AMN Healthcare is launching a private offering of $400.0 million.

What will the proceeds from the offering be used for?

Proceeds will redeem $500.0 million of 2027 Notes and cover offering expenses.

Who qualifies to purchase the 2031 Notes?

The 2031 Notes are offered to qualified institutional buyers and non-U.S. persons.

Will the 2031 Notes be registered under the Securities Act?

No, the 2031 Notes will not be registered under the Securities Act.

How many patients did AMN Healthcare reach in 2024?

In 2024, AMN Healthcare professionals reached nearly 15 million patients.

Last updated: Sep 22, 2025